GE HealthCare Technologies Inc. (GEHC)
NasdaqGS · Price as of · Nasdaq Real Time Price
- Profitability13/20
Profitable but shrinking: $1.91B over the last four reported quarters, down from $2.48B the year before.
- Insider buying vs selling20/20
Insiders are net buyers: 8 open-market buys worth $6.4M vs 0 sells worth $0 across the last 20 Form 4 filings.
- Dilution and offerings11/15
Share count down 0.7% in a year with 2 offering-related filings. Mild dilution.
- Analysts18
- Implied upside+15.0%
- Target range$70.00 to $96.00
- EPS expected$1.20 +13%
- A year ago$1.07
- Revenue expected$5.35B +4.0%
- Estimate range$1.18 to $1.25
GEHC closed at $71.73 on Aug 28, up 2.6% since Jul 30. Chart read: price above the 50-day moving average but below the 200-day; the 50-day is below the 200-day (downtrend structure); trading at 43% of the 52-week range ($59.49 to $88.16).
Insider buying and selling at GE HealthCare Technologies Inc. (GEHC)
The most recent Form 4 on record for GE HealthCare Technologies Inc. (GEHC) is May 22, 2026, when Kevin Lobo, Director, bought $641,800 of stock. An open-market purchase is money the filer chose to put in.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Kevin Lobo · Director | Buy | $641,800 | May 22, 2026 | Own call |
| H Lawrence Culp Jr · Director | Buy | $5.0M | May 6, 2026 | Own call |
| James Saccaro · Chief Financial Officer | Buy | $200,585 | May 1, 2026 | Own call |
| Peter J Arduini · President and CEO | Buy | $249,827 | April 30, 2026 | Own call |
| Frank R Jimenez · GC & Corporate Secretary | Buy | $105,788 | April 30, 2026 | Own call |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 18, 2026 | FORM 4 |
| 8-K | August 18, 2026 | 8-K |
| SCHEDULE 13G/A | August 7, 2026 | View on EDGAR |
| SCHEDULE 13G/A | August 7, 2026 | View on EDGAR |
| 8-K | July 29, 2026 | 8-K |
| 10-Q | July 29, 2026 | 10-Q |
| 8-K | July 29, 2026 | 8-K |
| 8-K | July 23, 2026 | 8-K |
Articles that mention GE HealthCare Technologies without it being the main subject.
Frequently asked questions
When does GEHC report earnings?
GE HealthCare Technologies Inc. (GEHC) is scheduled to report quarterly results on October 28, 2026 (estimated). The 15-analyst consensus is $1.20 per share on revenue of $5.35B for the quarter ending September 30, 2026, against $1.07 and $5.14B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for GEHC?
18 analysts cover GE HealthCare Technologies Inc. (GEHC). The consensus rating is Buy. The average price target is $82.50, in a range of $70.00 to $96.00.
Are insiders buying or selling GEHC?
We track Form 4 filings for GE HealthCare Technologies Inc. (GEHC). The activity listed on this page shows 5 open-market purchases. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see GEHC SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 18, 2026.